Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more
Drägerwerk AG & Co. KGaA (DGWPF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.050x
Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DGWPF) has a cash flow conversion efficiency ratio of 0.050x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($74.94 Million) by net assets ($1.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Drägerwerk AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Drägerwerk AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Drägerwerk AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Drägerwerk AG & Co. KGaA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
0.052x |
|
Guangdong Haomei New Material Co Lt
SHE:002988
|
0.017x |
|
Seegene Inc
KQ:096530
|
0.037x |
|
Shen Ma Industry Co Ltd
SHG:600810
|
0.029x |
|
Hanwang Technology Co Ltd
SHE:002362
|
-0.036x |
|
Topdanmark AS
PINK:TPDKY
|
-0.107x |
|
Cisen Pharmaceutical Co Ltd
SHG:603367
|
0.050x |
|
MORIMATSU INT.H.C. (HK)
F:1S5
|
N/A |
Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (2005–2024)
The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.54 Billion | $167.31 Million | 0.109x | -19.11% |
| 2023-12-31 | $1.41 Billion | $189.68 Million | 0.135x | +223.13% |
| 2022-12-31 | $1.32 Billion | $-144.23 Million | -0.109x | -135.80% |
| 2021-12-31 | $1.26 Billion | $384.89 Million | 0.305x | -31.37% |
| 2020-12-31 | $1.03 Billion | $459.98 Million | 0.445x | +191.27% |
| 2019-12-31 | $1.08 Billion | $164.42 Million | 0.153x | +3936.11% |
| 2018-12-31 | $1.08 Billion | $4.09 Million | 0.004x | -97.18% |
| 2017-12-31 | $1.07 Billion | $143.34 Million | 0.134x | -31.07% |
| 2016-12-31 | $1.00 Billion | $195.32 Million | 0.195x | +361.89% |
| 2015-12-31 | $945.93 Million | $39.86 Million | 0.042x | -79.90% |
| 2014-12-31 | $896.61 Million | $187.98 Million | 0.210x | +150.33% |
| 2013-12-31 | $815.97 Million | $68.34 Million | 0.084x | -65.54% |
| 2012-12-31 | $727.20 Million | $176.75 Million | 0.243x | +10.90% |
| 2011-12-31 | $729.62 Million | $159.91 Million | 0.219x | -36.34% |
| 2010-12-31 | $636.56 Million | $219.14 Million | 0.344x | -29.92% |
| 2009-12-31 | $393.82 Million | $193.45 Million | 0.491x | +160.88% |
| 2008-12-31 | $517.64 Million | $97.47 Million | 0.188x | -39.66% |
| 2007-12-31 | $505.49 Million | $157.75 Million | 0.312x | +88.90% |
| 2006-12-31 | $539.99 Million | $89.21 Million | 0.165x | +41.12% |
| 2005-12-31 | $257.68 Million | $30.16 Million | 0.117x | -- |